RESUMO
Antibody-mediated receptor activation is successfully used to develop medical treatments. If the activation induces a pathological response, such antibodies are also excellent tools for defining molecular mechanisms of target receptor malfunction and designing rescue therapies. Prominent examples are naturally occurring autoantibodies inducing the severe blistering disease pemphigus vulgaris (PV). In the great majority of patients, the antibodies bind to the adhesion receptor desmoglein 3 (Dsg3) and interfere with cell signaling to provoke severe blistering in the mucous membranes and/or skin. The identification of a comprehensive causative signaling network downstream of antibody-targeted Dsg3 receptors (e.g., shown by pharmacological activators or inhibitors) is currently being discussed as a basis to develop urgently needed first-line treatments for PV patients. Although polyclonal PV IgG antibodies have been used as proof of principle for pathological signal activation, monospecific anti-Dsg3 antibodies are necessary and have been developed to identify pathological Dsg3 receptor-mediated signal transduction. The experimental monospecific PV antibody AK23, produced from hybridoma cells, was extensively tested in our laboratory in both in vitro and in vivo models for PV and proved to recapitulate the clinicopathological features of PV when generated using the standardized production and purification protocols described herein. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Bovine IgG stripping from FBS and quality control Basic Protocol 2: AK23 hybridoma expansion and IgG production Basic Protocol 3: AK23 IgG purification Basic Protocol 4: AK23 IgG quality control Support Protocol 1: Detection of endotoxin levels Support Protocol 2: Detection and removal of mycoplasma.
Assuntos
Desmogleína 3 , Pênfigo , Pênfigo/imunologia , Pênfigo/patologia , Desmogleína 3/imunologia , Animais , Humanos , Camundongos , Autoanticorpos/imunologia , Pesquisa Translacional BiomédicaRESUMO
We present two middle-aged patients with pruritic, crusted scalp erosions. Skin biopsy showed epidermal acantholysis with IgG and C3 intercellular deposits on direct immunofluorescence, leading to the diagnosis of localized pemphigus vulgaris. Resolution of the lesions without relapse occurred after low doses of oral prednisone and intralesional triamcinolone acetonide.
Assuntos
Pênfigo , Dermatoses do Couro Cabeludo , Humanos , Pênfigo/patologia , Pênfigo/diagnóstico , Pênfigo/tratamento farmacológico , Dermatoses do Couro Cabeludo/patologia , Dermatoses do Couro Cabeludo/tratamento farmacológico , Dermatoses do Couro Cabeludo/diagnóstico , Pessoa de Meia-Idade , Masculino , Triancinolona Acetonida/uso terapêutico , Triancinolona Acetonida/administração & dosagem , Feminino , Prednisona/uso terapêutico , Glucocorticoides/uso terapêutico , Couro Cabeludo/patologia , Acantólise/patologia , Acantólise/diagnósticoRESUMO
Keratinocytes in mucosal and skin tissues maintain tissue integrity via desmosomes and desmoglein-3 (Dsg3). Pemphigus Vulgaris (PV) is a life-threatening autoimmune blistering disease characterized by autoantibodies against Dsg3, disrupting desmosomes. Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates oxidative stress responses crucial for skin tissue protection. Although the pathogenesis of PV is known, the detailed molecular events remain unclear. This study investigates changes in Nrf2 expression in keratinocytes following pathogenic anti-Dsg3 antibody AK23 exposure, using dose- and time-dependent studies employing immunofluorescence analysis. N/TERT keratinocytes were cultured in keratinocytes serum-free medium and treated with AK23 at varying doses (5 µg/mL,40µg/mL,75µg/mL) and durations (2, 6, 24 h). Immunofluorescence staining was performed to assess the expression of Nrf2 and Dsg3. All fluorescent images were analyzed using ImageJ software. A dose-dependent increase in Dsg3 was noted following AK23 treatment, while Nrf2 expression and subcellular localization varied. Time-course analyses showed decreased Nrf2 at 24 h and increased Dsg3 levels. Early time-point (2 and 6 h) variations were evident in Nrf2 levels. This study highlights the impact of AK23 on Nrf2 expression, potentially disrupting Nrf2-mediated cytoprotection and implicating oxidative stress (ROS generation) in PV pathogenesis. Further investigation is necessary to validate the findings.
Assuntos
Desmogleína 3 , Queratinócitos , Fator 2 Relacionado a NF-E2 , Pênfigo , Espécies Reativas de Oxigênio , Pênfigo/imunologia , Pênfigo/metabolismo , Pênfigo/patologia , Fator 2 Relacionado a NF-E2/metabolismo , Queratinócitos/metabolismo , Queratinócitos/imunologia , Desmogleína 3/imunologia , Desmogleína 3/metabolismo , Humanos , Espécies Reativas de Oxigênio/metabolismo , Estresse Oxidativo , Anticorpos Monoclonais/farmacologia , Linhagem Celular , Autoanticorpos/imunologiaRESUMO
Interstitial lung disease (ILD) has been identified as a prevalent complication and significant contributor to mortality in individuals with pemphigus. In this study, a murine model of pemphigus was developed through the subcutaneous administration of serum IgG obtained from pemphigus patients, allowing for an investigation into the association between pemphigus and ILD. Pulmonary interstitial lesions were identified in the lungs of a pemphigus mouse model through histopathology, RT-qPCR and Sircol assay analyses. The severity of these lesions was found to be positively associated with the concentration of IgG in the injected serum. Additionally, DIF staining revealed the deposition of serum IgG in the lung tissue of pemphigus mice, indicating that the subcutaneous administration of human IgG directly impacted the lung tissue of the mice, resulting in damage. This study confirms the presence of pulmonary interstitial lesions in the pemphigus mouse model and establishes a link between pemphigus and ILD.
Assuntos
Modelos Animais de Doenças , Imunoglobulina G , Doenças Pulmonares Intersticiais , Pênfigo , Pênfigo/patologia , Animais , Camundongos , Doenças Pulmonares Intersticiais/etiologia , Doenças Pulmonares Intersticiais/patologia , Imunoglobulina G/sangue , Humanos , Pulmão/patologia , Pele/patologia , Feminino , Camundongos Endogâmicos BALB CAssuntos
Autoanticorpos , Autoantígenos , Colágeno Tipo XVII , Desmocolinas , Colágenos não Fibrilares , Pênfigo , Humanos , Pênfigo/imunologia , Pênfigo/patologia , Desmocolinas/imunologia , Autoanticorpos/sangue , Autoanticorpos/imunologia , Colágenos não Fibrilares/imunologia , Autoantígenos/imunologia , Feminino , Masculino , Pessoa de Meia-IdadeAssuntos
Fatores Imunológicos , Pênfigo , Rituximab , Pênfigo/tratamento farmacológico , Pênfigo/patologia , Humanos , Rituximab/administração & dosagem , Rituximab/uso terapêutico , Resultado do Tratamento , Fatores Imunológicos/administração & dosagem , Fatores Imunológicos/uso terapêutico , Feminino , Masculino , Pessoa de Meia-Idade , AdultoRESUMO
Pemphigus, a potentially lethal autoimmune skin disease, is mediated by desmoglein-specific antibodies, manifesting cutaneous and mucosal blisters and erosions. The interaction between multiple immune counterparts contributes to the progress of pemphigus. Currently, the emergence of bioinformatic analysis enables investigators to gain a global picture of the pemphigus immune network, based on the exhaustive pedigree annotation of multiple subsets. T helper subsets dominate the landscape as mentioned previously, and innate immune cells have been involved as well. Of particular interests is which phenotype of T cells orchestrates the autoimmune process and chronic inflammation in a certain condition. In this review, the circulatory and peripheral immune cells and cytokine components constituting the immune microenvironment are separately discussed to provide a perspective on pemphigus pathogenesis, with particular reference to insights provided by the bioinformation technique.
Assuntos
Pênfigo , Pênfigo/imunologia , Pênfigo/etiologia , Pênfigo/patologia , Humanos , Citocinas/metabolismo , Animais , Imunidade Inata , Autoimunidade , Autoanticorpos/imunologia , Pele/imunologia , Pele/patologia , Biologia Computacional/métodosAssuntos
Autoanticorpos , Desmogleína 3 , Penfigoide Bolhoso , Pênfigo , Humanos , Pênfigo/imunologia , Pênfigo/diagnóstico , Pênfigo/patologia , Desmogleína 3/imunologia , Penfigoide Bolhoso/imunologia , Penfigoide Bolhoso/diagnóstico , Penfigoide Bolhoso/patologia , Autoanticorpos/imunologia , Autoanticorpos/sangue , Mucosa Bucal/patologia , Mucosa Bucal/imunologia , Feminino , Masculino , IdosoRESUMO
Autoimmune dermatopathies are not common in horses. These autoimmune diseases can be idiopathic or triggered by an antigen such as drugs, vaccines, or neoplasia. The most common one is pemphigus foliaceus, which manifests as a pustular, crusting eruption. Other more common pustular diseases should be ruled out before considering pemphigus. Vasculitis is relatively common in horses and can be triggered by a variety of antigenic stimulations. Systemic lupus and true idiopathic autoimmune vasculitis are very rare in horses. Every effort should be made to reach a final diagnosis, as the prognosis for true idiopathic autoimmune skin diseases is poor.
Assuntos
Doenças Autoimunes , Doenças dos Cavalos , Dermatopatias , Cavalos , Animais , Doenças dos Cavalos/diagnóstico , Doenças dos Cavalos/imunologia , Doenças Autoimunes/veterinária , Doenças Autoimunes/diagnóstico , Dermatopatias/veterinária , Dermatopatias/diagnóstico , Pênfigo/veterinária , Pênfigo/diagnóstico , Pênfigo/patologia , Pênfigo/imunologiaRESUMO
Objective: To determine the concordance among clinical, histopathological and immunofluorescence as diagnostic methods for intraepidermal immunobullous disorders. METHODS: The prospective cross-sectional study was conducted at the Institute of Skin Diseases, Karachi, from December 2020 to December 2022, and comprised adult patients of either gender presenting with complaints of bullae, vesicles, pustules and crusts on the skin or mucous membrane. Diagnostic findings of each patient as obtained by clinical assessment, microscopy and direct immunofluorescence were compared. Data was analysed using SPSS 19. RESULTS: Of the 81 patients, 41(50.6%) were males and 40(49.4%) were females. The overall median age was 35 years (interquartile range: 23 years), with 66(75%) patients aged 19-55 years. The predominant body site involved was the trunk 49(60.5%), followed by mucosa 26(32.1%). Clinical diagnosis detected 80(98.7%) cases, compared to 76(93.8%) by microscopy and 81(100%) by direct immunofluorescence. Conclusion: Direct immunofluorescence was found to be the gold standard for a confirmatory diagnosis of intraepidermal immunobullous disorders, especially when clinical and histopathology findings were inconclusive.
Assuntos
Pênfigo , Dermatopatias , Adulto , Masculino , Feminino , Humanos , Técnica Direta de Fluorescência para Anticorpo , Estudos Transversais , Estudos Prospectivos , Pele/patologia , Vesícula , Pênfigo/diagnóstico , Pênfigo/patologiaRESUMO
OBJECTIVE: Pemphigus Vulgaris (PV) is a rare autoimmune disease that could cause laryngeal lesions; however, only a few studies have described the localization of the laryngeal lesions associated with this disease owing to its rarity. Therefore, this study aimed to determine the localization of laryngeal lesions in patients with PV. METHODS: Fourteen patients with PV accompanied by laryngeal or pharyngeal lesions, who underwent flexible laryngeal endoscopy performed by laryngologists, were examined retrospectively. RESULTS: The arytenoid area was the most frequently affected site in the larynx, followed by the epiglottis and aryepiglottic folds. Vocal folds and ventricular bands were the least affected. CONCLUSION: Lesions in the arytenoid area were observed more frequently in this study than in previous studies. This result suggests that a more careful inspection of arytenoid lesions in patients with PV is required under laryngeal fiber observation. Moreover, we proposed a novel classification system for laryngeal findings in patients with PV and a systematic observation method. This novel classification and method would be useful not only for determining the lesions but also for careful inspection in this field. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:3719-3725, 2024.
Assuntos
Doenças da Laringe , Laringoscopia , Pênfigo , Humanos , Pênfigo/patologia , Pênfigo/diagnóstico , Masculino , Feminino , Estudos Retrospectivos , Pessoa de Meia-Idade , Doenças da Laringe/patologia , Doenças da Laringe/diagnóstico , Laringoscopia/métodos , Adulto , Idoso , Cartilagem Aritenoide/patologia , Laringe/patologiaRESUMO
Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are two common subtypes of autoimmune bullous disease (AIBD). The key role of circulating autoreactive immune cells contributing to skin damage of AIBD has been widely recognized. Nevertheless, the immune characteristics in cutaneous lesions remain unclear. Here, we performed single-cell RNA sequencing (scRNA-seq) and single-cell VDJ sequencing (scRNA-seq) to generate transcriptional profiles for cells and T/B cell clonetype in skin lesions of BP and PV. We found that the proportions of NK&T, macrophages/ dendritic cells, B cells, and mast cells increased in BP and PV lesions. Then, BP and PV cells constituted over 75% of all myeloid cell subtypes, CD4+ T cell subtypes and CD8+ T cell subtypes. Strikingly, CD8+ Trm was identified to be expanded in PV, and located in the intermediate state of the pseudotime trajectory from CD8+ Tm to CD8+ Tem. Interestingly, CD8+ Tem and CD4+ Treg highly expressed exhaustion-related genes, especially in BP lesions. Moreover, the enhanced cell communication between stromal cells and immune cells like B cells and macrophages/ dendritic cells was also identified in BP and PV lesions. Finally, clone expansion was observed in T cells of BP and PV compared with HC, while CD8+ Trm represented the highest ratio of hyperexpanded TCR clones among all T cell subtypes. Our study generally depicts a large and comprehensive single-cell landscape of cutaneous lesions and highlights immune cell features in BP and PV. This offers potential research targets for further investigation.
Assuntos
Penfigoide Bolhoso , Pênfigo , Análise de Célula Única , Humanos , Penfigoide Bolhoso/imunologia , Penfigoide Bolhoso/genética , Penfigoide Bolhoso/patologia , Pênfigo/imunologia , Pênfigo/genética , Pênfigo/patologia , Análise de Célula Única/métodos , Pele/imunologia , Pele/patologia , Linfócitos T CD8-Positivos/imunologia , Feminino , Masculino , Análise de Sequência de RNA , Linfócitos T CD4-Positivos/imunologia , Macrófagos/imunologia , Linfócitos B/imunologia , Idoso , Células Dendríticas/imunologia , Pessoa de Meia-IdadeRESUMO
Paraneoplastic pemphigus is a rare, life-threatening autoimmune disease that is clinically characterized by mostly extensive and refractory mucosal erosions and polymorphous skin lesions. We report here on a 16-year-old girl with isolated oral erosions, in whom mucosal pemphigoid was initially suspected and after treatment with prednisolone and dapsone marked improvement was achieved. However, a few months later the patient developed massive respiratory insufficiency as a result of bronchiolitis obliterans, so that a lung transplant was planned. As part of the preparatory diagnostic workup, unicentric, abdominally localized Castleman's disease was diagnosed, which ultimately led to the diagnosis of paraneoplastic pemphigus as evidenced by envoplakin autoantibodies. Tumor resection and subsequent lung transplantation achieved good results with sustained mucocutaneous remission.
Assuntos
Hiperplasia do Linfonodo Gigante , Síndromes Paraneoplásicas , Pênfigo , Humanos , Feminino , Hiperplasia do Linfonodo Gigante/complicações , Hiperplasia do Linfonodo Gigante/imunologia , Hiperplasia do Linfonodo Gigante/diagnóstico , Hiperplasia do Linfonodo Gigante/tratamento farmacológico , Hiperplasia do Linfonodo Gigante/patologia , Adolescente , Pênfigo/diagnóstico , Pênfigo/imunologia , Pênfigo/complicações , Pênfigo/patologia , Pênfigo/tratamento farmacológico , Síndromes Paraneoplásicas/diagnóstico , Síndromes Paraneoplásicas/imunologia , Síndromes Paraneoplásicas/patologia , Transplante de Pulmão , Bronquiolite Obliterante/imunologia , Bronquiolite Obliterante/diagnóstico , Bronquiolite Obliterante/etiologia , Bronquiolite Obliterante/tratamento farmacológicoAssuntos
Máscaras , Pênfigo , Humanos , Pênfigo/patologia , Pênfigo/etiologia , Máscaras/efeitos adversos , Masculino , Feminino , Nariz/patologia , Pessoa de Meia-IdadeAssuntos
Gengiva , Penfigoide Mucomembranoso Benigno , Pênfigo , Humanos , Pênfigo/patologia , Pênfigo/diagnóstico , Penfigoide Mucomembranoso Benigno/diagnóstico , Penfigoide Mucomembranoso Benigno/patologia , Feminino , Biópsia/métodos , Masculino , Gengiva/patologia , Pessoa de Meia-Idade , Idoso , Estudos de Coortes , Adulto , Estudos RetrospectivosRESUMO
INTRODUCTION: Pemphigus is a group of bullous disorders of the skin characterized by the formation of autoantibodies present in the intercellular junction of the epidermis. Diagnosis is made by clinical, histopathological examination, and DIF. As DIF needs frozen sections, fluorescent tagged antibodies, UV light microscope for examination, and trained personnel, its non-availability makes a definitive diagnosis challenging. AIMS AND OBJECTIVES: To evaluate the utility of IHC staining of complements and Ig in cases of Pemphigus. MATERIALS AND METHODS: Twenty-six diagnosed cases of Pemphigus were stained by Peroxidase immunohistochemical method using monoclonal antibody to IgG, IgA, IgM, IgG4, C3, C4 d with DAB as chromogen. Pemphigus cases include twenty of pemphigus vulgaris (PV), four cases of pemphigus foliaceous (PF), and two of pemphigus vegetans (Pveg). Positivity was defined as the deposition of Ig and complements as distinct, continuous brown staining of keratinocytes at intercellular junctions. RESULT: On IHC total of 20 PV 17 showed positivity (85%) for IgG, 11 (55%) C4d, 19 (95%) C3d, and 16 (80%) IgG4 deposits at the intercellular junction of the epidermis. All cases of PF showed a deposit of IgG, with three (75%) cases for IgG4, C3d, and C4d. Both cases of Pveg showed positivity for IgG and C4d while one case was negative for IgG4 and C3d. The overall IgG, C3, IgG4, and C4d expression for pemphigus was seen in 88%, 88%, 76.9%, and 61.5% of cases. The relation between these markers, combination of IgG and C3, was best related to each other ( P value = 0.80). The sensitivities for IgG, IgG4, and C3 were 77.8%%, 73%, and 73% resp. CONCLUSION: We conclude that IHC is a useful tool in the diagnosis of PV with the highest sensitivity of IgG and C3d. The combination of IgG and C3d could replace the DIF in almost all of our cases, so IHC on FFPE sections be used as an alternative method to DIF.
Assuntos
Imunoglobulinas , Imuno-Histoquímica , Pênfigo , Humanos , Pênfigo/diagnóstico , Pênfigo/imunologia , Pênfigo/patologia , Imuno-Histoquímica/métodos , Técnica Direta de Fluorescência para Anticorpo/métodos , Coloração e Rotulagem/métodos , Masculino , Feminino , Imunoglobulina G , Pele/patologiaRESUMO
The oral mucosa can be involved in a wide variety of mucocutaneous conditions that may present primarily in the mouth or affect other cutaneous or mucosal sites. Many of these conditions are immune mediated and typically present as inflammatory mucosal pathology. Patients experiencing such conditions usually seek medical evaluation and treatment due to the associated pain and discomfort, and occasionally taste disturbance or dysphagia and the overall deterioration in the oral health-related quality of life. These conditions share some common features and there could be some overlap in their clinical presentation, which can lead to delays in diagnosis and proper management of patients. Clinicians dealing with such disorders, including dermatologists, need to be aware of the oral manifestations of mucocutaneous conditions, their clinical features, underlying mechanisms, diagnostic approaches, and treatment options, as well as the recent advances in the research on these conditions. This review provides a comprehensive, evidence-based reference for clinicians, with updated insights into a group of immune mediated conditions known to cause oral mucosal pathology. Part one will cover oral lichen planus, erythema multiforme and systemic lupus erythematosus, while part two will cover recurrent aphthous stomatitis, pemphigus vulgaris and mucous membrane pemphigoid, in addition to the less common disorders linear IgA disease, dermatitis herpetiformis and epidermolysis bullosa.